Aims: The prognosis of patients with intrahepatic cholangiocarcinoma (ICC) remains poor in terms of overall survival (OS) and recurrence rate. Mortalin, a stress chaperone, has been reported to be involved in carcinogenesis and metastasis. However, its role in ICC has not been defined.
Methods: Mortalin expression in tumour samples from patients with ICC was examined by Western blot and immunohistochemistry, and correlation between its expression and clinicopathological features was assessed. In addition, invasion, migration proliferation and apoptosis, and the expression of epithelial-mesenchymal transition (EMT)-related markers in ICC cells were assessed after mortalin depletion. Finally, the prognostic significance of mortalin in patients with ICC was further evaluated by Kaplan-Meier and Cox regression analysis.
Results: We provide evidence that expression of mortalin in human ICC tissues is higher than that in matched peritumoural tissues. The interference of mortalin expression inhibited the proliferation and invasion of ICC cells in vitro. Mechanistically, inhibition of mortalin expression in ICC cells upregulated E-cadherin expression and decreased vimentin and snail expression. Clinically, a high level of mortalin in ICC samples was associated with loss of E-cadherin, and increased expression of vimentin and snail. Patients with ICC and high mortalin expression had a shorter OS and a higher recurrence rate. Multivariate analysis revealed that mortalin overexpression was an independent prognostic indicator for patients with ICC.
Conclusions: Mortalin may promote cell proliferation and invasion via induction of EMT of ICC cells. A high level of mortalin may be used as a prognostic biomarker and therapeutic target for patients with ICC.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1136/jclinpath-2016-204251 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mitochondrial Iron Metabolism as a Potential Key Mediator of PD-L1 Thermal Regulation.
Cancers (Basel)
November 2024
Department of Radiation Oncology, University of Iowa, Iowa City, IA 52242-1181, USA.
Article Synopsis
- Glioblastoma (GBM) is a highly aggressive brain cancer with very low survival rates, and laser interstitial thermal therapy (LITT) has emerged as a promising surgical option to reduce tumor burden and modulate immune responses.
- The study investigated how thermal therapy and radiation affect the immune checkpoint PD-L1 in U87 GBM cells, particularly focusing on the differences between IDH-mutant and IDH-wildtype cells.
- Results indicated that thermal therapy effectively killed GBM cells in a temperature-dependent manner, especially at higher temperatures, and notably reduced PD-L1 levels in U87 cells, which correlated with increased expression of a specific mitochondrial enzyme linked to iron metabolism.
Estrogen-related receptor alpha promotes thyroid tumor cell survival via a tumor subtype-specific regulation of target gene networks.
Oncogene
July 2024
Department of Biochemistry, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.
Mortalin (encoded by HSPA9) is a mitochondrial chaperone often overexpressed in cancer through as-yet-unknown mechanisms. By searching different RNA-sequencing datasets, we found that ESRRA is a transcription factor highly correlated with HSPA9 in thyroid cancer, especially in follicular, but not C cell-originated, tumors. Consistent with this correlation, ESRRA depletion decreased mortalin expression only in follicular thyroid tumor cells.
View Article and Find Full Text PDFMortalin promotes the evolution of androgen-independent prostate cancer through Wnt/β-catenin signaling pathway.
Cancer Cell Int
June 2024
Department of Health Examination Centre, Affiliated Yanbian University Hospital, Yanji, China.
Article Synopsis
- - Prostate cancer (PC) is a significant health issue for men, with the androgen-independent variant being particularly challenging due to its slow progression and resistance to hormone therapy.
- - Mortalin, an oncogene, plays a crucial role in tumor migration and invasion, and its expression is found to be increased in prostate cancer tissues.
- - Research indicates that Mortalin influences the epithelial-mesenchymal transition (EMT) through the Wnt/β-catenin signaling pathway, suggesting it could be a valuable target for new immunotherapy approaches in treating prostate cancer.
HSPA9/mortalin inhibition disrupts erythroid maturation through a TP53-dependent mechanism in human CD34+ hematopoietic progenitor cells.
Cell Stress Chaperones
April 2024
Department of Biomedical Sciences, West Virginia School of Osteopathic Medicine, Lewisburg, WV, USA. Electronic address:
Myelodysplastic syndromes (MDS) are a heterogeneous group of clonal hematopoietic stem cell malignancies characterized by abnormal hematopoietic cell maturation, increased apoptosis of bone marrow cells, and anemia. They are the most common myeloid blood cancers in American adults. The full complement of gene mutations that contribute to the phenotypes or clinical symptoms in MDS is not fully understood.
View Article and Find Full Text PDFMETTL3-mediated HSPA9 m6A modification promotes malignant transformation and inhibits cellular senescence by regulating exosomal mortalin protein in cervical cancer.
Cancer Lett
April 2024
Department of Science and Innovation, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, 518100, PR China; The Third School of Clinical Medicine, Southern Medical University, Guangzhou, Guangdong, 510515, PR China; Shenzhen Key Laboratory of Viral Oncology, Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, 518100, PR China. Electronic address:
The role of RNA methyltransferase 3 (METTL3) in tumor progression when tethered to aberrantly expressed oncogenes remains unknown. In especial, the correlation between cervical cancer (CCa)-derived exosomes and m6A methylation in malignant traits of cervical epithelium is currently elusive. Mortalin expression was found to be up-regulated in plasma exosomes isolated from CCa patients.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!